Dysport (abobotulinumtoxinA)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
ADVERSE REACTIONS
The following serious adverse reactions are discussed below and elsewhere in labeling: (additions)
...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Abobotulinumtoxin A | Drugs & Pharmacology